CVS HEALTH Corp — Director's Dealing 2023

Mar 1, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CVS HEALTH Corp (CVS)
CIK: 0000064803
Period of Report: 2023-02-28

Reporting Person: Clark James David (SVP, Cont & Chief Acct Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-02-28	Common Stock	F	179	$83.54	Disposed	26151.2554	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock (Restricted)	12671	Direct

Footnotes

F1: Surrender of shares in payment of withholding taxes due upon the vesting of a restricted stock award.